NPI: 1124272547 · LIBERTYVILLE, IL 60048 · Clinical Medical Laboratory · NPI assigned 11/12/2008
Authorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
| Authorized Official | RICHARDSON, KARA (VP MANAGED HEALTH) |
| NPI Enumeration Date | 11/12/2008 |
Other providers sharing the same authorized official: RICHARDSON, KARA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,137 | $675K |
| 2019 | 22,172 | $941K |
| 2020 | 10,632 | $412K |
| 2021 | 13 | $29.06 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 19,810 | 4,675 | $1.52M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 6,887 | 1,221 | $257K |
| 97161 | 1,711 | 1,257 | $106K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 762 | 703 | $42K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,924 | 2,372 | $20K |
| 71046 | Radiologic examination, chest; 2 views | 1,845 | 1,469 | $18K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,119 | 776 | $13K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 683 | 644 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 373 | 235 | $5K |
| J3490 | Unclassified drugs | 449 | 147 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 340 | 277 | $4K |
| 87081 | 2,769 | 2,219 | $3K | |
| 92523 | 37 | 12 | $2K | |
| 73630 | 217 | 182 | $2K | |
| 97165 | 195 | 112 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 620 | 545 | $2K |
| 97162 | 19 | 12 | $2K | |
| 87400 | 735 | 654 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 185 | 102 | $2K |
| 80053 | Comprehensive metabolic panel | 581 | 419 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 14 | 14 | $1K |
| 85610 | 689 | 344 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 803 | 508 | $1K |
| 73564 | 104 | 84 | $1K | |
| 73610 | 59 | 57 | $796.59 | |
| 84443 | Thyroid stimulating hormone (TSH) | 141 | 126 | $714.41 |
| 81003 | 644 | 517 | $381.47 | |
| 73502 | 21 | 13 | $337.72 | |
| 81025 | 368 | 305 | $278.88 | |
| 72110 | 12 | 12 | $221.79 | |
| 73030 | 20 | 13 | $197.70 | |
| 87480 | 21 | 13 | $193.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 16 | 12 | $181.96 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 16 | 12 | $181.96 |
| 73130 | 49 | 42 | $179.03 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 52 | 46 | $176.95 |
| 87660 | 37 | 25 | $173.64 | |
| 87510 | 21 | 13 | $167.50 | |
| 87077 | 77 | 62 | $146.37 | |
| 81002 | 241 | 210 | $109.78 | |
| 80061 | Lipid panel | 66 | 64 | $64.97 |
| 36415 | Collection of venous blood by venipuncture | 19 | 12 | $64.39 |
| 84439 | 31 | 26 | $39.29 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 47 | 43 | $34.04 |
| 87147 | 42 | 42 | $22.16 | |
| 85027 | 14 | 14 | $17.14 | |
| 85652 | 17 | 12 | $3.93 | |
| J7510 | Prednisolone oral, per 5 mg | 24 | 12 | $2.13 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 28 | 28 | $0.00 |